A detailed history of Captrust Financial Advisors transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Captrust Financial Advisors holds 14,409 shares of VRTX stock, worth $5.88 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares
14,409
Previous 14,102 2.18%
Holding current value
$5.88 Million
Previous $6.61 Million 1.39%
% of portfolio
0.02%
Previous 0.02%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$460.0 - $505.78 $141,220 - $155,274
307 Added 2.18%
14,409 $6.7 Million
Q2 2024

Aug 14, 2024

SELL
$392.81 - $485.53 $1 Million - $1.24 Million
-2,546 Reduced 15.29%
14,102 $6.61 Million
Q1 2024

May 15, 2024

SELL
$407.69 - $446.08 $2.23 Million - $2.44 Million
-5,461 Reduced 24.7%
16,648 $6.96 Million
Q4 2023

Feb 14, 2024

BUY
$343.0 - $410.68 $1.11 Million - $1.33 Million
3,245 Added 17.2%
22,109 $9 Million
Q3 2023

Nov 14, 2023

SELL
$338.18 - $362.46 $747,377 - $801,036
-2,210 Reduced 10.49%
18,864 $6.56 Million
Q2 2023

Aug 14, 2023

BUY
$314.42 - $351.91 $166,013 - $185,808
528 Added 2.57%
21,074 $7.42 Million
Q1 2023

May 15, 2023

BUY
$283.23 - $323.1 $297,957 - $339,901
1,052 Added 5.4%
20,546 $6.47 Million
Q4 2022

Feb 15, 2023

SELL
$285.76 - $321.48 $7,429 - $8,358
-26 Reduced 0.13%
19,494 $5.63 Million
Q3 2022

Nov 16, 2022

SELL
$273.83 - $305.53 $254,661 - $284,142
-930 Reduced 4.55%
19,520 $5.65 Million
Q2 2022

Aug 23, 2022

SELL
$234.96 - $292.55 $1.14 Million - $1.42 Million
-4,846 Reduced 19.16%
20,450 $5.76 Million
Q2 2022

Aug 16, 2022

BUY
$234.96 - $292.55 $1.38 Million - $1.71 Million
5,858 Added 30.14%
25,296 $7.12 Million
Q1 2022

May 16, 2022

BUY
$221.42 - $260.97 $609,347 - $718,189
2,752 Added 16.49%
19,438 $5.07 Million
Q4 2021

Feb 14, 2022

SELL
$177.01 - $223.45 $462,350 - $583,651
-2,612 Reduced 13.54%
16,686 $3.66 Million
Q3 2021

Nov 16, 2021

BUY
$181.39 - $202.99 $668,422 - $748,018
3,685 Added 23.6%
19,298 $3.5 Million
Q2 2021

Aug 16, 2021

BUY
$187.49 - $221.1 $2.03 Million - $2.4 Million
10,833 Added 226.63%
15,613 $3.15 Million
Q1 2021

May 17, 2021

BUY
$207.02 - $241.31 $643,211 - $749,750
3,107 Added 185.71%
4,780 $1.03 Million
Q4 2020

Feb 16, 2021

SELL
$207.01 - $276.09 $608,195 - $811,152
-2,938 Reduced 63.72%
1,673 $395,000
Q3 2020

Nov 17, 2020

BUY
$255.65 - $303.1 $165,405 - $196,105
647 Added 16.32%
4,611 $1.26 Million
Q2 2020

Aug 14, 2020

BUY
$225.48 - $295.8 $506,879 - $664,958
2,248 Added 131.0%
3,964 $1.14 Million
Q1 2020

May 15, 2020

BUY
$199.77 - $247.81 $150,227 - $186,353
752 Added 78.01%
1,716 $387,000
Q4 2019

Feb 14, 2020

BUY
$166.71 - $223.91 $122,698 - $164,797
736 Added 322.81%
964 $212,000
Q3 2019

Nov 14, 2019

BUY
$166.23 - $187.09 $997 - $1,122
6 Added 2.7%
228 $39,000
Q2 2019

Aug 13, 2019

BUY
$164.61 - $190.37 $24,526 - $28,365
149 Added 204.11%
222 $41,000
Q1 2019

May 15, 2019

SELL
$163.73 - $194.7 $3,438 - $4,088
-21 Reduced 22.34%
73 $13,000
Q4 2018

Feb 13, 2019

SELL
$151.91 - $192.21 $2,886 - $3,651
-19 Reduced 16.81%
94 $16,000
Q3 2018

Nov 15, 2018

BUY
$167.73 - $192.74 $1,341 - $1,541
8 Added 7.62%
113 $22,000
Q2 2018

Aug 13, 2018

BUY
$145.72 - $169.96 $7,577 - $8,837
52 Added 98.11%
105 $18,000
Q1 2018

May 15, 2018

SELL
$151.6 - $177.13 $303 - $354
-2 Reduced 3.64%
53 $8,000
Q4 2017

Feb 14, 2018

BUY
$137.28 - $155.55 $2,471 - $2,799
18 Added 48.65%
55 $8,000
Q3 2017

Feb 16, 2018

BUY
$148.13 - $162.24 $5,480 - $6,002
37
37 $6,000

Others Institutions Holding VRTX

About VERTEX PHARMACEUTICALS INC


  • Ticker VRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 256,691,008
  • Market Cap $105B
  • Description
  • Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...
More about VRTX
Track This Portfolio

Track Captrust Financial Advisors Portfolio

Follow Captrust Financial Advisors and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Captrust Financial Advisors, based on Form 13F filings with the SEC.

News

Stay updated on Captrust Financial Advisors with notifications on news.